Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab.
暂无分享，去创建一个
J. Maul | A. Kühl | R. Glauben | M. Schumann | B. Siegmund | D. Lissner | E. Sonnenberg | A. Kruglov | F. Schmidt | Yasmina Rodriguez-Sillke | I. Freise | B. Jessen